endo-f,-N-acetylhexosaminidase which degrades the glycosaminoglycans hyaluronic acid, chondroitin, chondroitin 4-and 6-sulphates and, to a variable extent, depending on the source, dermatan sulphate. Several studies resulting in highly purified enzyme preparations have been reported (Borders & Raftery, 1968; Yang & Srivastava, 1975; Srivastava & Farooqui, 1979 ). The last paper described the first use of an affinity matrix (heparin-Sepharose).
Hyaluronidase has found widespread clinical usage, especially in aiding the local dispersal of drugs. It has also proved to be an invaluable analytical tool in connective-tissue research. A promising application in the treatment of myocardial infarction has been proposed (Maroko & Braunwald, 1973; Maclean et al., 1976) .
Many studies have shown that certain glycosaminoglycans, namely heparin and some preparations of dermatan sulphate, are inhibitors of hyaluronidase (Hadidian et al., 1957; Houck, 1957) . The aim of the present study has been to investigate the interactions between hyaluronidase and a number of possible inhibitors, ultimately with a view to devising a purification scheme based on affinity chromatography.
Abbreviations used: AH-Sepharose 4B, 1,6-diaminohexane-Sepharose 4B; SDS, sodium dodecyl sulphate. * Present address: Chelsea College (University of London), Manresa Road, London SW3 6LX, U.K. Vol. 199 Experimental Materials Potassium hyaluronate from human umbilical cords (batch C20 D) was purchased from Miles Laboratories (Slough, Berks., U.K.) and further purified by the cetylpyridinium chloride fractionation method of Scott (1960) . Heparin (Cifonelli et al., 1958) to give an iduronate-rich dermatan sulphate. Copper was removed by dialysis against 1 M-NaCI/5 mM-EDTA, then distilled water and finally passage through Amberlite monobed MB3 resin.
Preparation of desulphated dermatan sulphate and de-N/O-sulphated, re-N-acetylated heparin Dermatan sulphate was solvolytically desulphated by the method of Nagasawa et al. (1977) . Heparin was de-N-sulphated by the method of Inoue & Nagasawa (1976) . The resulting free amino groups were acetylated with an excess of acetic anhydride in 0.25 M-sodium phosphate buffer, pH 7.5 at 0°C (Riordan & Vailee, 1972) . Amino-group substitution was monitored by using trinitrobenzenesulphonic acid (Satake et al., 1960) . Finally, de-O-sulphation was performed by the method of Nagasawa et al. (1977) .
Analytical methods
Total hexuronic acid was determined by the orcinol (Brown, 1946) and carbazole (Dische, 1947) methods. Amino acid and hexosamine analyses of glycosaminoglycans were performed on a LKB 4101 Autoanalyser (LKB Biochrom Ltd., Cambridge, U.K.) after hydrolysis in 4M-HCI at 1000C for 10h under a nitrogen atmosphere. Sulphate content was monitored by the method of Stone & Bradley (1967) .
Chondroitinase-AC or -ABC digestions of dermatan sulphate were performed in 1 ml of 0.1 MTris/HCl/0. 1 M-sodium acetate, pH 7.3, with the addition of 0.1 unit of either enzyme. After incubation at 370C for 6h, a further 0.1 unit was added and incubation was continued for a further 9 h. Digested samples were chromatographed on a Sephadex G-200 column in 1 M-NaCl. The void volume and total volume were determined with Dextran Blue and D-glucuronolactone respectively.
Preparation of glycan-substituted AH-Sepharose gels Dermatan sulphate, desulphated dermatan sulphate and desulphated, re-N-acetylated heparin were dissolved in 0.1 M-sodium acetate buffer, pH 5.4, containing 0.15 M-NaCl, and digested with approx. 0.06-0.09 unit of bovine testicular hyaluronidase (3.9 units/mg prepared in our laboratory) per mg of glycan, at 370C for 24h. Samples of the digests were chromatographed on a Sephadex G-200 column in 1 M-NaCl. The digests were boiled and centrifuged (1500g, 10min) to remove protein. Polymeric glycosaminoglycans were precipitated with 0.3M-calcium acetate/0.5 M-acetic acid and 50% (v/v) ethanol .
The three treated glycosaminoglycans, plus heparin, were coupled via their carboxy groups to AH-Sepharose 4B by using 1-ethyl-3-(3-dimethylaminopropyl)carbodi-imide hydrochloride and the procedure recommended by the manufacturer (Pharmacia). After exhaustive washing of the gels, the unsubstituted amino groups were blocked by acetylation with an excess of acetic anhydride (Riordan & Vallee, 1972) .
The amounts of glycosaminoglycan bound were determined by hexosamine analysis of the gels, after hydrolysis in 4M-HCI at 1000C for 10h under nitrogen. The vacuum-dried hydrolysates were taken up in 0.35M-sodium citrate buffer, pH 5.28, filtered through a Millipore membrane (0.22,um pore size) and then analysed on a LKB 4101 Autoanalyser by using a one-step elution with 0.35M-sodium citrate buffer, pH 5.28.
Assay ofhyaluronidase
Hyaluronidase activity was determined colorimetrically by a modification of the method of Aronson & Davidson (1967) . The reaction mixture consisted of 0.4 ml of sodium hyaluronate (1 mg/ml) in 0.1 M-sodium acetate buffer/0.15M-NaCl, pH 5.4, to which was added 0.1 ml of enzyme solution. After incubation at 370C for 15min, N-acetylglucosamine end-group colour was developed by the method of Reissig et al. (1955) .
The modification by Doak & Zahler (1979) , using a pH 3.8 incubation in the presence of bovine serum albumin (1 mg/ml), was used for assaying highly purified enzyme and for the determination of specific activities. One unit of enzyme activity (IUPAC) (Humphrey, 1957) . Protein was determined by the methods of Sedmak & Grossberg (1977) and Lowry et al. (1951) , with bovine serum albumin as a standard.
Plastic vessels and columns and silicone-treated glassware were used for all enzyme operations to minimize the inactivation of hyaluronidase by adsorption on glass surfaces (Rasmussen, 1954) .
Chromatography of hyaluronidase on glycan-substituted AH-Sepharose gels
The four glycan-substituted gels and acetylated AH-Sepharose 4B (a control gel) were packed into plastic columns. Crude hyaluronidase was 1981 chromatographed on the gels at low ionic strength, pH 4 and/or pH 6. Bound protein was generally eluted with a linear concentration gradient of NaCl. Fractions were analysed for hyaluronidase activity and protein (by the A 280). NaCl concentrations were monitored with a conductivity meter (model MC-1, Mark V; Electronic Switchgear London Ltd., Hitchin, Herts., U.K.).
All experiments were performed at 40C. Further details are given in the legends to the Figures.
Purification ofhyaluronidase
(1) Chromatography on dermatan sulphate-substituted AH-Sepharose 4B. Crude hyaluronidase (600mg) was dissolved in 30ml of 20mM-sodium acetate, adjusted to pH 6 with 1 M-NaOH and centrifuged at 15OOg for 10min. The supernatant was applied to a dermatan sulphate-AH-Sepharose 4B column (1.8 cm x 6.5 cm) equilibrated with 20mM-sodium acetate buffer, pH 6, and eluted with the same buffer at a flow rate of 9.6 ml/h; 4.8 ml fractions were collected. The column was then eluted with 20mM-sodium acetate buffer, pH 4, followed by a linear 0-1 M-NaCl gradient (total volume 100ml) in the same pH 4.0 buffer (3 ml fractions were collected).
Hyaluronidase-active fractions were pooled, dialysed against 20mM-sodium acetate buffer, pH 6.0, and then concentrated by ultrafiltration over a' Diaflo PM 10 membrane (Amicon, High Wycombe, Bucks., U.K.) in a Chemlab C50 ultrafiltration cell (Chemlab Instruments, Hornchurch, Essex, U.K.).
(2) Chromatography on acetylated AH-Sepharose 4B. The concentrated hyaluronidase fraction was centrifuged at 15OOg for 10min. The supernatant was applied to an acetylated AH-Sepharose 4B column (1.8cm x 6.0 cm) equilibrated with 20mM-sodium acetate buffer, pH 6.0, and eluted with the same buffer at a flow rate of 9 ml/h; 4.5 ml fractions were collected. The column was washed free of bound protein with 1 M-NaCl in pH 6 buffer. The hyaluronidase-active fractions were pooled and concentrated by dialysis against buffered poly(ethylene glycol) (30mg/ml).
Polyacrylamide-gel electrophoresis
This was performed by the method of Brewer & Ashworth (1969) , with 7.5% acrylamide gels at pH4.3 and 8.9. Both upper and lower gels were polymerized by using riboflavin and light from a Shandon 'Photopol' fluorescent lamp (Shandon Southern Products Ltd., Runcorn, Cheshire, U.K.). Methyl Green and Bromophenol Blue were used as respective marker dyes. Gels were stained for protein with 0.5% (w/v) Kenacid Blue R in 45% (v/v) methanol and 10% (v/v) acetic acid, and then destained in 7.5% (v/v) acetic acid/5% (v/v) methanol. Enzyme activity was located by slicing unstained gels into 2mm lengths and elution of the individual slices overnight at 40C in 0.5 ml of 0.1 M-sodium acetate buffer, pH 3.8, containing 0.15 M-NaCl and 5 mg of bovine serum albumin/ml. Then 0.1ml samples were assayed for hyaluronidase activity. A duplicate gel was stained for protein.
Polyacrylamide-gel electrophoresis in the presence of SDS was performed by the method of Weber & Osborn (1969) in 10%-acrylamide gels. Bovine serum albumin fraction V (mol.wt. 68000), catalase (bovine liver, mol.wt. 58000), ovalbumin (mol.wt. 43000), carbonic anhydrase (bovine erythrocytes, mol.wt. 29000), haemoglobin (bovine, mol.wt. 15500) and lysozyme (egg white, mol.wt. 14 300) were used as molecular-weight markers.
Results

Preparation ofdermatan sulphate
Two copper precipitations of the 36% (v/v)-ethanol fraction yielded 945 mg of a dermatan sulphate containing less than 1% of the total hexosamine as N-acetylglucosamine. The 'carbazole/orcinol' ratio of 0.295 is higher than the value of 0.23 expected for pure L-iduronic acid , indicating the presence of D-glucuronic acid. It can be estimated that the polymer contains approx. 95% L-iduronic acid and 5% D-glucuronic acid (Fransson et al., 1968) . (Stone & Bradley, 1967) Hexosamine analysis estimated the coupling yields for the four substituted gels as: dermatan sulphate, 1.6,mol of disaccharide/ml of swollen gel; desulphated dermatan sulphate, 0.12,mol/ml; heparin, 3.4,mol/ml; de-N/O-sulphated, re-Nacetylated heparin, 1.2,umol/ml.
Hyaluronidase bound to heparin-substituted gel in pH 7 buffer containing 0.15 M-NaCl, and was eluted with 0.2-0.25M-NaCl (Fig. 2a) . In comparison, gel substituted with de-N/O-sulphated, re-N-acetylated heparin did not bind a significant amount of enzyme at either pH 4 or 6 (results not shown). The very small amount of enzyme that did bind was eluted with 0.05-0.1 M-NaCl.
Dermatan sulphate-substituted gel bound hyaluronidase at pH 6, which could be eluted with approx. 0.15 M-NaCl (Fig. 2b) . At pH 4 the enzyme was bound more strongly, requiring 0.2M-NaCl for elution, but the overall capacity of the gel for enzyme appeared to be decreased (Fig. 2c) . Desulphated dermatan sulphate-substituted gel did not bind hyaluronidase at pH 6 (results not shown).
Interestingly, acetylated AH-Sepharose 4B, although not binding hyaluronidase, did bind a significant amount of protein at pH 6.
Purification of hyaluronidase
(1) Chromatography on dermatan sulphate-substituted AH-Sepharose *4B. Hyaluronidase bound to the column at pH 6. Elution with pH 4 buffer removed a large proportion of the bound protein, after which the hyaluronidase was eluted with the NaCl gradient (Fig. 3a) . The fractions indicated by horizontal arrows were pooled, dialysed and concentrated to give a solution containing 7 mg of enzyme with an activity of 6.25 units/mg. 1981 (a) Heparin-substituted AH-Sepharose 4B. Column size 1.4 cm x 16 cm; loading, 100mg of crude enzyme; eluent, 50mM-Tris/HCI buffer, pH 7.0, containing 0.15 M-NaCl, followed by a NaCl gradient (0.15-0.5M in pH 7.0 buffer); flow rate, 5 ml/h. (b) Dermatan sulphate-substituted AH-Sepharose 4B. Column size, 1.8cm x 6.5 cm; loading, 250mg of crude enzyme; eluent, 20mM-sodium acetate buffer, pH 6.0, followed by a NaCl gradient (0-1 M in pH 6.0 buffer); flow rate, 11.3 ml/h; fraction volume, 5.65 ml. (c) Dermatan sulphate-substituted AH-Sepharose 4B. Column size, 1.8 cm x 6.5 cm; loading, 250mg of crude enzyme; eluent, 20mM-sodium acetate buffer, pH4.0, followed by a NaCl gradient (0-0.5 M in pH 4.0 buffer); flow rate, 1 1.3 ml/h; fraction volume, 5.65 ml. Analyses: protein A 280 (0) or pg/ml (0); hyaluronidase activity (A); NaCl gradient ( ). Sedmak & Grossberg (1977) in step 2 and by that of Lowry et al. (1951) in step 3.
Step (1 (2) Chromatography on acetylated AH-Sepharose 4B. The majority of the protein from Step 1 bound to the column at pH 6, while the hyaluronidase was eluted straight through (Fig. 3b) . The pooled wash-through fractions yielded 1.47mg of enzyme, with a specific activity of 19.1 units/mg. The overall purification was 130-fold, with a yield of 56% (Table   2 ).
Polyacrylamide-gel electrophoresis
Polyacrylamide-gel electrophoresis of purified enzyme at pH4.3 consistently revealed two bands.
Detection of hyaluronidase activity by slicing up an unstained gel reveals a broad band of activity, which can be resolved by a longer electrophoresis time into two bands corresponding to the stained protein bands on a duplicate gel (Fig. 4) F 61000-62000 is the currently accepted one for testicular hyaluronidase (Borders & Raftery, 1968; Yang & Srivastava, 1974) .
Discussion
The limited susceptibility of both the dermatan sulphate and desulphated dermatan sulphate preparations to digestion by testicular hyaluronidase would indicate that resistance is due primarily to the preponderance of L-iduronic acid residues. Similarly, the presence of a-hexosaminidic linkages seems to explain the complete resistance of de-N/O-sulphated, re-N-acetylated heparin to hyaluronidase.
The binding of hyaluronidase to gels substituted with dermatan sulphate or heparin was to be expected from their known competitive inhibition of hyaluronidase action (Houck, 1957) . The binding to heparin appears to be the slightly stronger of the two, as measured by the relative concentrations of NaCl required for elution of the enzyme. Binding is effectively abolished after desulphation of both these glycosaminoglycans. Binding thus appears to be dependent on the extent of sulphation.
The dermatan sulphate-substituted gel formed the basis of a two-step purification scheme which gave enzyme with a specific activity of 19.1 units/mg in a high yield. It is noteworthy that the Coomassie Blue-based protein assay of Sedmak & Grossberg (1977) indicated only 0.72 mg of protein in the purified preparation (i.e. a specific activity of 39.2 units/mg), relative to a bovine serum albumin calibration curve. This is only 49% of the protein (1.47mg) indicated by the assay of Lowry et al. (1951) . This variability of response to different proteins is a known deficiency of Coomassie Blue-based assays (Pierce & Suelter, 1977; Van Kley & Hale, 1977) . This purification compares with that of Srivastava & Farooqui (1979) , using a four-step procedure based on heparin-Sepharose chromatography, which gave enzyme of 104000 (Segrest & Jackson, 1972) , and any change in the carbohydrate moiety (e.g. by glycosidase action) could have a significant effect on the protein's mobility.
Even small changes in the amino acid composition can result in larger changes in mobility than would be expected from the corresponding molecularweight change (e.g. de Jong et al., 1978) . Gorham (1974) has similarly obtained complex patterns on SDS/polyacrylamide-gel electrophoresis from otherwise highly purified hyaluronidase.
In conclusion, the scheme reported here can provide for the preparation of highly purified bovine testicular hyaluronidase in fewer stages and with a higher yield than previously reported methods.
